Ancora Advisors’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76K | Hold |
1,100
| – | – | ﹤0.01% | 1651 |
|
|
2025
Q1 | $1.34K | Hold |
1,100
| – | – | ﹤0.01% | 1537 |
|
|
2024
Q4 | $2.08K | Sell |
1,100
-5,000
| -82% | -$9.45K | ﹤0.01% | 1538 |
|
|
2024
Q3 | $32.6K | Hold |
6,100
| – | – | ﹤0.01% | 1073 |
|
|
2024
Q2 | $45K | Hold |
6,100
| – | – | ﹤0.01% | 947 |
|
|
2024
Q1 | $72.8K | Hold |
6,100
| – | – | ﹤0.01% | 848 |
|
|
2023
Q4 | $48.1K | Buy |
6,100
+5,000
| +455% | +$39.4K | ﹤0.01% | 922 |
|
|
2023
Q3 | $4.86K | Sell |
1,100
-4,325
| -80% | -$19.1K | ﹤0.01% | 1359 |
|
|
2023
Q2 | $189K | Hold |
5,425
| – | – | 0.01% | 646 |
|
|
2023
Q1 | $118K | Hold |
5,425
| – | – | ﹤0.01% | 728 |
|
|
2022
Q4 | $117K | Hold |
5,425
| – | – | ﹤0.01% | 767 |
|
|
2022
Q3 | $132K | Buy |
5,425
+4,325
| +393% | +$105K | ﹤0.01% | 799 |
|
|
2022
Q2 | $22K | Buy |
+1,100
| New | +$22K | ﹤0.01% | 1365 |
|